eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

Boehringer Ingelheim Limited

Ellesfield Avenue, Bracknell, Berkshire, RG12 8YS
Telephone: +44 (0)1344 424 600
Fax: +44 (0)1344 741 298
WWW: http://www.boehringer-ingelheim.co.uk
Medical Information Direct Line: +44 (0)1344 741 286
Medical Information e-mail: medinfo@bra.boehringer-ingelheim.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Patient Information Leaflet last updated on the eMC: 22/09/2010
PIL Oramorph Concentrated Oral Solution

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 22/09/2010 and displayed until Current
Reasons for adding or updating:
  • Change to dosage and administration
Updated on 04/03/2010 and displayed until 22/09/2010
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 02/12/2009 and displayed until 04/03/2010
Reasons for adding or updating:
  • Change to Further Information section
  • Correction of spelling/typing errors
  • Change to warnings or special precautions for use
  • Change to storage instructions
  • Change to side-effects
  • Change to drug interactions
  • Change to information about pregnancy or lactation
Updated on 12/08/2009 and displayed until 02/12/2009
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 04/06/2009 and displayed until 12/08/2009
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 16/12/2008 and displayed until 04/06/2009
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 03/09/2008 and displayed until 16/12/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 28/11/2007 and displayed until 03/09/2008
Reasons for adding or updating:
  • Change to date of revision
Updated on 03/11/2006 and displayed until 28/11/2007
Reasons for adding or updating:
  • Change to date of revision
Updated on 12/05/2006 and displayed until 03/11/2006
Reasons for adding or updating:
  • Change to date of revision
Updated on 01/07/2003 and displayed until 12/05/2006
Reasons for adding or updating:
  • Update to PIL
Updated on 19/12/2000 and displayed until 01/07/2003
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   morphine sulphate